Landos Biopharma Inc. (LABP)
NASDAQ: LABP
· Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM
Landos Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.8M | -21.93M | -21.05M | -23.08M | -30.45M | -39.28M | -54.14M | -58.85M | -43.47M | -38.42M | -29.67M | -25.29M | -34.17M |
Depreciation & Amortization | 12K | 44K | 1.76M | 1.76M | 1.98M | 2.3M | 632K | 680K | 506K | 196K | 176K | 164K | 151K |
Stock-Based Compensation | 1.01M | 971K | 922K | 874K | 1.25M | 1.97M | 4.2M | 4.36M | 4.04M | 4.12M | 1.73M | 1.37M | 1.06M |
Other Working Capital | 3.65M | 4.96M | 5.36M | 3.33M | 952K | -601K | 1.38M | 326K | 4.97M | 1.63M | -1.87M | -1.6M | -4.01M |
Other Non-Cash Items | -1.45M | n/a | -208K | 177K | 385K | -696K | 804K | 312K | 78K | 64K | 314K | 325K | 693K |
Deferred Income Tax | 1.52M | n/a | -1.52M | -1.52M | -1.52M | n/a | n/a | 832K | 1.27M | 1.09M | 2.09M | 1.26M | 824K |
Change in Working Capital | 2.97M | 443K | 889K | -2.76M | -9.09M | -10.07M | -5.63M | -5.73M | 6.58M | 5.89M | 1.96M | 5.24M | -718K |
Operating Cash Flow | -20.8M | -20.48M | -19.21M | -24.55M | -37.44M | -45.77M | -54.13M | -58.4M | -31M | -27.06M | -23.39M | -16.93M | -32.15M |
Capital Expenditures | n/a | n/a | -7K | -145K | -180K | -187K | -143K | -269K | -383K | -440K | -567K | -315K | -225K |
Cash Acquisitions | n/a | n/a | 63K | 201K | 236K | 478K | 301K | 42K | 7K | -123K | 79K | 200K | 200K |
Purchase of Investments | n/a | n/a | -3.67M | -3.67M | -6.32M | -7.34M | -12.61M | -93.12M | -94.5M | -174.85M | -173.21M | -97.03M | -101.85M |
Sales Maturities Of Investments | 4.67M | 7.78M | 19.12M | 35.56M | 60.07M | 77.5M | 76.79M | 151.32M | 127.73M | 116.59M | 120.2M | 36.41M | 42.45M |
Other Investing Acitivies | -57K | -57K | 3.68M | 3.82M | 3.85M | 3.61M | 45K | 28K | -7K | 123K | -79K | -200K | -200K |
Investing Cash Flow | 4.67M | 7.78M | 19.18M | 35.76M | 57.66M | 74.06M | 64.39M | 58M | 32.85M | -58.71M | -53.57M | -60.94M | -59.62M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 19.57M | 16.57M | -3M | -3M | -3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.94M | 8.73M | 13.57M | 13.57M | 13.67M | n/a | 624K | 843K | 843K | 91.61M | 92.5M | 92.28M | 92.28M |
Financial Cash Flow | -1.94M | 11.73M | 13.57M | 13.57M | 13.67M | n/a | 624K | 843K | 843K | 91.61M | 92.5M | 92.28M | 92.28M |
Net Cash Flow | -16.19M | 909K | 13.58M | 24.81M | 33.96M | 28.34M | 10.99M | 554K | 2.72M | 5.89M | 15.42M | 14.38M | 425K |
Free Cash Flow | -20.8M | -20.48M | -19.21M | -24.7M | -37.62M | -45.96M | -54.27M | -58.67M | -31.39M | -27.5M | -23.96M | -17.25M | -32.38M |